{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T09:47:32Z","timestamp":1762249652770,"version":"3.37.3"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1124\/jpet.118.253286","type":"journal-article","created":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T09:43:45Z","timestamp":1542879825000},"page":"229-236","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Reversal and Prevention of the Respiratory-Depressant Effects of Heroin by the Novel \u03bc-Opioid Receptor Antagonist Methocinnamox in Rhesus Monkeys"],"prefix":"10.1016","volume":"368","author":[{"given":"Lisa R.","family":"Gerak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David R.","family":"Maguire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James H.","family":"Woods","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen M.","family":"Husbands","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Disney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles P.","family":"France","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.118.253286_bib1","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1080\/03007995.2017.1334637","article-title":"Use of naloxone nasal spray 4 mg in the community setting: a survey of use by community organizations","volume":"34","author":"Avetian","year":"2018","journal-title":"Curr Med Res Opin"},{"key":"10.1124\/jpet.118.253286_bib2","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s002130050068","article-title":"Methoclocinnamox: time course of changes in alfentanil-reinforced responding in rhesus monkeys","volume":"148","author":"Briscoe","year":"2000","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.118.253286_bib3","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0022-3565(24)39155-4","article-title":"Methocinnamox is a potent, long-lasting, and selective antagonist of morphine-mediated antinociception in the mouse: comparison with clocinnamox, \u03b2-funaltrexamine, and \u03b2-chlornaltrexamine","volume":"294","author":"Broadbear","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.118.253286_bib4","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/S0022-3565(25)21207-1","article-title":"Methoclocinnamox: agonist and antagonist effects of a novel long-lasting opioid in rhesus monkeys","volume":"279","author":"Butelman","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.118.253286_bib5","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/ALN.0b013e3181c38c25","article-title":"Incidence, reversal, and prevention of opioid-induced respiratory depression","volume":"112","author":"Dahan","year":"2010","journal-title":"Anesthesiology"},{"key":"10.1124\/jpet.118.253286_bib6","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S0022-3565(25)19958-8","article-title":"Apparent affinity of opioid antagonists in morphine-treated rhesus monkeys discriminating between saline and naltrexone","volume":"252","author":"France","year":"1990","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.118.253286_bib7","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.addbeh.2016.05.013","article-title":"Academic physicians\u2019 and medical students\u2019 perceived barriers toward bystander administered naloxone as an overdose prevention strategy","volume":"61","author":"Gatewood","year":"2016","journal-title":"Addict Behav"},{"key":"10.1124\/jpet.118.253286_bib8","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s002130050606","article-title":"Studies on benzodiazepines and opioids administered alone and in combination in rhesus monkeys: ventilation and drug discrimination","volume":"137","author":"Gerak","year":"1998","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.118.253286_bib9","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00213-007-0787-y","article-title":"Time-dependent decreases in apparent pA2 values for naltrexone studied in combination with morphine in rhesus monkeys","volume":"193","author":"Gerak","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.118.253286_bib10","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1001\/jama.2008.802","article-title":"Patterns of abuse among unintentional pharmaceutical overdose fatalities","volume":"300","author":"Hall","year":"2008","journal-title":"JAMA"},{"key":"10.1124\/jpet.118.253286_bib11","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.amepre.2015.03.040","article-title":"Emergency department visits and overdose deaths from combined use of opioids and benzodiazepines","volume":"49","author":"Jones","year":"2015","journal-title":"Am J Prev Med"},{"key":"10.1124\/jpet.118.253286_bib12","first-page":"881","article-title":"Alcohol involvement in opioid pain reliever and benzodiazepine drug abuse-related emergency department visits and drug-related deaths - United States, 2010","volume":"63","author":"Jones","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1124\/jpet.118.253286_bib13","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.drugalcdep.2012.07.004","article-title":"Polydrug abuse: a review of opioid and benzodiazepine combination use","volume":"125","author":"Jones","year":"2012","journal-title":"Drug Alcohol Depend"},{"key":"10.1124\/jpet.118.253286_bib14","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0014-2999(00)00039-X","article-title":"Buprenorphine and methoclocinnamox: agonist and antagonist effects on respiratory function in rhesus monkeys","volume":"391","author":"Kishioka","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.118.253286_bib15","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0014-2999(00)00279-X","article-title":"Acute dependence on, but not tolerance to, heroin and morphine as measured by respiratory effects in rhesus monkeys","volume":"398","author":"Kishioka","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.118.253286_bib16","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/add.13326","article-title":"Are take-home naloxone programmes effective? Systematic review utilizing application of the Bradford Hill criteria","volume":"111","author":"McDonald","year":"2016","journal-title":"Addiction"},{"key":"10.1124\/jpet.118.253286_bib17","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0022-3565(24)38137-6","article-title":"Nitrocinnamoyl and chlorocinnamoyl derivatives of dihydrocodeinone: in vivo and in vitro characterization of mu-selective agonist and antagonist activity","volume":"289","author":"McLaughlin","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.118.253286_bib18","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.brainres.2005.07.060","article-title":"Comparison of the antinociceptive effect of acute morphine in female and male Sprague-Dawley rats using the long-lasting mu-antagonist methocinnamox","volume":"1058","author":"Peckham","year":"2005","journal-title":"Brain Res"},{"key":"10.1124\/jpet.118.253286_bib19","doi-asserted-by":"crossref","first-page":"107","DOI":"10.15585\/mm6604a4","article-title":"Multiple fentanyl overdoses - New Haven, Connecticut, June 23, 2016","volume":"66","author":"Tomassoni","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1124\/jpet.118.253286_bib20","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0022-3565(24)37642-6","article-title":"Analgesic, respiratory and heart rate effects of cannabinoid and opioid agonists in rhesus monkeys: antagonist effects of SR 141716A","volume":"286","author":"Vivian","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.118.253286_bib21","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/sj.bjp.0706247","article-title":"Opioid antagonists differ according to negative intrinsic efficacy in a mouse model of acute dependence","volume":"145","author":"Walker","year":"2005","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.118.253286_bib22","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0022-3565(25)09651-X","article-title":"Buprenorphine antagonism of mu opioids in the rhesus monkey tail-withdrawal procedure","volume":"273","author":"Walker","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.118.253286_bib23","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejphar.2018.05.041","article-title":"Ventilatory-depressant effects of opioids alone and in combination with cannabinoids in rhesus monkeys","volume":"833","author":"Weed","year":"2018","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.118.253286_bib24","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/2042098614564776","article-title":"Review of naloxone safety for opioid overdose: practical considerations for new technology and expanded public access","volume":"6","author":"Wermeling","year":"2015","journal-title":"Ther Adv Drug Saf"},{"key":"10.1124\/jpet.118.253286_bib25","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0022-3565(25)10977-4","article-title":"Effects of buprenorphine and other opioid agonists and antagonists on alfentanil- and cocaine-reinforced responding in rhesus monkeys","volume":"261","author":"Winger","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.118.253286_bib26","first-page":"874","article-title":"Characterization of [3H]clocinnamox binding in mouse brain membranes","volume":"1","author":"Zernig","year":"1995","journal-title":"Analgesia (Elmsford N Y)"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524260857?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524260857?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.118.253286","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T19:55:02Z","timestamp":1739994902000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524260857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S0022356524260857"],"URL":"https:\/\/doi.org\/10.1124\/jpet.118.253286","relation":{},"ISSN":["0022-3565"],"issn-type":[{"type":"print","value":"0022-3565"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reversal and Prevention of the Respiratory-Depressant Effects of Heroin by the Novel \u03bc-Opioid Receptor Antagonist Methocinnamox in Rhesus Monkeys","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.118.253286","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}